Cancer diagnosis, risk assessment and prediction of therapeutic response by means of DNA methylation markers.
about
Methylation Markers for the Identification of Body Fluids and Tissues from Forensic Trace Evidence.CDH1 methylation in preoperative peritoneal washes is an independent prognostic factor for gastric cancerApplication of DNA methylation biomarkers for endometrial cancer management.Epigenetics: an important challenge for ICP-MS in metallomics studies.Aberrant methylation and reduced expression of RASSF1A in Ewing sarcoma.Outcome prediction and risk assessment by quantitative pyrosequencing methylation analysis of the SFN gene in advanced stage, high-risk, neuroblastic tumor patients.
P2860
Cancer diagnosis, risk assessment and prediction of therapeutic response by means of DNA methylation markers.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Cancer diagnosis, risk assessm ...... ns of DNA methylation markers.
@ast
Cancer diagnosis, risk assessm ...... ns of DNA methylation markers.
@en
type
label
Cancer diagnosis, risk assessm ...... ns of DNA methylation markers.
@ast
Cancer diagnosis, risk assessm ...... ns of DNA methylation markers.
@en
prefLabel
Cancer diagnosis, risk assessm ...... ns of DNA methylation markers.
@ast
Cancer diagnosis, risk assessm ...... ns of DNA methylation markers.
@en
P356
P1433
P1476
Cancer diagnosis, risk assessm ...... ans of DNA methylation markers
@en
P2093
Karim Elmasry
P356
10.1155/2007/293138
P50
P577
2007-01-01T00:00:00Z